- £329.06m
- £787.46m
- £2.76bn
- 51
- 66
- 24
- 42
2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,085 | 1,873 | 2,291 | 2,745 | 2,761 |
Cost of Revenue | |||||
Gross Profit | 539 | 470 | 602 | 711 | 700 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 2,173 | 2,044 | 2,272 | 2,688 | 2,757 |
Operating Profit | -87.9 | -172 | 19.2 | 56.2 | 3.8 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -113 | -195 | -15.9 | 27.5 | -31.9 |
Provision for Income Taxes | |||||
Net Income After Taxes | -124 | -201 | -28.3 | 15.5 | -43.4 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -125 | -132 | -28.3 | 15.5 | -43.4 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -125 | -132 | -28.3 | 15.5 | -43.4 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.012 | -0.09 | -0.002 | 0.054 | 0.009 |
Dividends per Share |